Microfluidic CE Purification for Radiopharmaceuticals

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current microfluidic systems face challenges in purifying large volumes of crude reaction products from PET tracer synthesis due to the limited sample volume capacity of preparative capillary electrophoresis (CE), which is typically suited for small-scale analytical applications, and the need for significant scaling up that increases radioactivity decay and operational impracticality.

Innovation Solution

A CE-based microfluidic purification system is developed, allowing for the purification of larger volumes by scaling up the injection volume through increased diameter or length of the injection plug, and integrating multiple microfluidic chips for separation and detection, with a single chip capable of injection, purification, and detection, and incorporating radiation detection and fraction collection to isolate the desired product.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If the injection volume is scaled up to purify larger volumes of crude reaction product, then the sample capacity is improved, but the separation performance deteriorates due to increased radioactivity decay and operational impracticality

Engineering Contradiction:
Improvesample volume capacityVSAvoidseparation performance
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

The patent transitions from traditional capillary electrophoresis (1D separation in a narrow capillary) to microfluidic chip-based electrophoresis with 2D/3D separation channels. This dimensional expansion allows larger sample volumes to be injected and separated effectively, resolving the contradiction between sample capacity and separation performance by providing additional spatial dimensions for both sample accommodation and separation resolution.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Solution Approach 2:

The patent modifies key parameters of the electrophoresis system including channel dimensions, applied voltage, and buffer composition to optimize separation performance for larger sample volumes. By changing these parameters, the system maintains effective separation while accommodating increased sample capacity, thus resolving the contradiction between quantity and reliability.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If the length of the separation channel is increased to maintain separation performance with larger injection plugs, then the separation performance is improved, but the separation time increases resulting in more radioactivity decay

Engineering Contradiction:
Improveseparation performanceVSAvoidseparation time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

Instead of solely increasing channel length (1D approach), the patent utilizes wider and taller separation channels (2D/3D approach) to accommodate larger injection plugs while maintaining separation efficiency. This dimensional change allows sufficient separation performance to be achieved with shorter channel lengths, thereby reducing separation time and radioactivity decay.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Solution Approach 2:

The patent applies high voltage at the beginning of the separation process to accelerate the separation of charged species. This preliminary high-field action enables faster separation in reduced time, compensating for the larger sample volume without requiring proportionally longer channel lengths, thus minimizing radioactivity decay.

Inventive Principle:
Principle #10Preliminary action

3Quantity of substance

If the diameter of the injection plug is increased to load more sample, then the sample capacity is improved, but the separation performance deteriorates due to higher voltage requirements

Engineering Contradiction:
Improveinjection volumeVSAvoidoperational impracticality
Core Design Contradiction:
Quantity of substanceVSEase of operation

Solution Approach 1:

The patent transitions to microfluidic chips with expanded channel dimensions (width and height) to accommodate larger injection volumes. This dimensional expansion allows increased sample capacity without requiring impractically high voltages, as the larger cross-sectional area provides more space for charge distribution and reduces electrical stress, making operation practical and manageable.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This system enables efficient purification of radiopharmaceuticals by increasing sample capacity while maintaining separation performance, reducing radioactivity decay, and minimizing radiation shielding, thus facilitating low-cost, on-demand production of PET tracers with high sensitivity and automation.

Implementation Method 1

CE is a chemical separation technique that relies on an electric field to drive a sample through a capillary or a microchannel. The separation of charged species is based on their respective interactions with the applied electric field.

Methodology Applied
Scientific EffectCapillary electrophoresis: Capillary Electrophoresis

Implementation Method 2

CE is a chemical separation technique that relies on an electric field to drive a sample through a capillary or a microchannel.

Methodology Applied
Scientific EffectElectric field: Electric Field

Implementation Method 3

Another object of the CE-based microfluidic purification system is to incorporate a method of measuring radioactivity of the sample. Radiation detection may be linked to fraction collection so that the desired product peak can be captured from the crude reaction mixture.

Methodology Applied
Scientific EffectRadiation detection: Radiation

Data Source

PatentUS11660571B2Microscale device and method for purification of radiopharmaceuticals
Publication Date: 2023.05.30 RGT UNIV OF CALIFORNIA
  • US11660571B2 patent drawing
  • US11660571B2 patent drawing
  • US11660571B2 patent drawing

AI summary

A microfluidic chip device for the purification of radiochemical compounds includes a chip having an injection channel and intersecting branch channels with a plurality of valves are located along the injection channel and branch channels and configured to retain a plug of solution containing the radiochemical compound. The chip further includes a serpentine channel segment (for separation) coupled to the output of the injection channel. A high voltage power source advances the plug of solution through the purification region and into the downstream fraction collection channel. The chip includes a downstream fraction collection channel coupled to the serpentine channel segment and having an optical and radiation detection regions. One or more branch fraction channels intersect with the fraction collection channel and include valves located therein so that the radiochemical compound that is detected using a radiation detector is directed into the desired branch fraction channel for subsequent use.